Literature DB >> 11570811

Poly(ADP-ribose) polymerase cleavage during apoptosis: when and where?

C Soldani1, M C Lazzè, M G Bottone, G Tognon, M Biggiogera, C E Pellicciari, A I Scovassi.   

Abstract

Poly(ADP-ribose) polymerase-1 (PARP-1) plays the active role of "nick sensor" during DNA repair and apoptosis, when it synthesizes ADP-ribose from NAD(+) in the presence of DNA strand breaks. Moreover, PARP-1 becomes a target of apoptotic caspases, which originate two proteolytic fragments of 89 and 24 kDa. The precise relationship between PARP-1 activation and degradation during apoptosis is still a matter of debate. In human Hep-2 cells driven to apoptosis by actinomycin D, we have monitored PARP-1 activity by the mAb 10H, which is specific for the ADP-ribose polymers, and we have observed that poly(ADP-ribose) synthesis is a very early response to the apoptotic stimulus. The analysis of the presence and fate of the p89 proteolytic fragment revealed that PARP-1 proteolysis by caspases is concomitant with poly(ADP-ribose) synthesis and that p89 migrates from the nucleus into the cytoplasm in late apoptotic cells with advanced nuclear fragmentation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11570811     DOI: 10.1006/excr.2001.5293

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  42 in total

1.  Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes.

Authors:  Emmanuel I Papadopoulos; George M Yousef; Andreas Scorilas
Journal:  Tumour Biol       Date:  2015-04-02

2.  Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling.

Authors:  Marek Los; Malgorzata Mozoluk; Davide Ferrari; Anna Stepczynska; Christopher Stroh; Andrea Renz; Zdenko Herceg; Zhao-Qi Wang; Klaus Schulze-Osthoff
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

Review 3.  The Molecular Physiopathogenesis of Islet Amyloidosis.

Authors:  Diti Chatterjee Bhowmick; Sanghamitra Singh; Saurabh Trikha; Aleksandar M Jeremic
Journal:  Handb Exp Pharmacol       Date:  2018

Review 4.  Pleiotropic role of PARP1: an overview.

Authors:  Vikas Kumar; Anurag Kumar; Khursheed Ul Islam Mir; Vandana Yadav; Shyam Singh Chauhan
Journal:  3 Biotech       Date:  2021-12-04       Impact factor: 2.406

5.  Proteasome regulates turnover of toxic human amylin in pancreatic cells.

Authors:  Sanghamitra Singh; Saurabh Trikha; Anjali Sarkar; Aleksandar M Jeremic
Journal:  Biochem J       Date:  2016-06-23       Impact factor: 3.857

6.  Dorzolamide synergizes the antitumor activity of mitomycin C against Ehrlich's carcinoma grown in mice: role of thioredoxin-interacting protein.

Authors:  Belal M Ali; Sawsan A Zaitone; Samia A Shouman; Yasser M Moustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-12       Impact factor: 3.000

7.  Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models.

Authors:  Jeong Won Park; Li Zhao; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2013-06-20       Impact factor: 6.166

8.  Enzyme-assisted photosensitization activates different apoptotic pathways in Rose Bengal acetate treated HeLa cells.

Authors:  Maria Grazia Bottone; Cristiana Soldani; Annunzia Fraschini; Anna Cleta Croce; Giovanni Bottiroli; Tania Camboni; Anna Ivana Scovassi; Carlo Pellicciari
Journal:  Histochem Cell Biol       Date:  2008-11-14       Impact factor: 4.304

9.  Intracellular distribution of Tankyrases as detected by multicolor immunofluorescence techniques.

Authors:  M G Bottone; G Santin; C Soldani; P Veneroni; A I Scovassi; C Alpini
Journal:  Eur J Histochem       Date:  2012-01-20       Impact factor: 3.188

10.  Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells.

Authors:  Yekaterina Y Zaytseva; Xin Wang; R Chase Southard; Natalie K Wallis; Michael W Kilgore
Journal:  Mol Cancer       Date:  2008-12-05       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.